Results 111 to 120 of about 1,163 (152)

Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategy

open access: yesExploratory Research in Clinical and Social Pharmacy
Background: Multicomponent strategies can reduce benzodiazepine (BZD) use. BenzoStopJuntos (Spanish for “Stop Benzos Together”), a multidisciplinary deprescribing programme of the Andalusian Health Service, supports patients to taper/stop BZD through ...
Ingrid Ferrer López   +8 more
doaj   +1 more source

Pilot psychotherapy program for the deprescription of benzodiazepines for anxiety disorders [PDF]

open access: yesAnsiedad y Estrés, 2021
Antonieta Also Fontanet   +6 more
openaire   +1 more source

Predicting Antidepressant Deprescription with Machine Learning Using Administrative Data

open access: yes
The high prevalence of failed antidepressant deprescription attempts makes it difficult for clinicians to identify suitable candidates for discontinuation. In this study, we use the Pharmaceutical Benefits Scheme (PBS) dataset, which contains rich longitudinal dispensing data from Australian primary care and developed supervised models to predict ...
Ranwala, R A D L M K, Andrade, A.Q.
openaire   +1 more source

Deprescription, what are we talking about? [PDF]

open access: yesFarmacia Hospitalaria, 2017
Marta Gutiérrez-Valencia   +1 more
doaj   +1 more source

BZRA DEPRESCRIPTION ON ACUTE GERIATRIC UNITS

open access: yes, 2021
Sibille, François-Xavier   +5 more
openaire   +2 more sources

Editorial: Ketogenic metabolic therapies in prevention & treatment of non-communicable diseases

open access: yesFrontiers in Nutrition
David Cavan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy